Related Experiment Video
Updated: Nov 1, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020
David J Gladstone1, M Patrice Lindsay2, James Douketis3
1Division of Neurology, Department of Medicine, and Regional Stroke Centre, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, Toronto, Canada.
Insights
The 2020 Canadian Stroke Best Practice Recommendations offer updated guidance for preventing recurrent ischemic stroke by managing vascular risk factors. This includes new evidence on therapies for atrial fibrillation, lipid lowering, and diabetes.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- The Canadian Stroke Best Practice Recommendations (CSBPR) provide evidence-based guidelines for stroke care.
- Secondary stroke prevention is crucial for reducing recurrence and improving patient outcomes.
Purpose of the Study:
- To present the 2020 update of the CSBPR for secondary stroke prevention.
- To incorporate new evidence and expert opinions for managing modifiable vascular risk factors.
Main Methods:
- Systematic review of current evidence and expert consensus.
- Development of recommendations covering triage, diagnostics, lifestyle, and pharmacotherapy.
Main Results:
- Simplified triage and assessment for transient ischemic attack (TIA) and minor stroke.
- Updated recommendations for dual antiplatelet therapy, anticoagulation for atrial fibrillation, lipid management, diabetes treatment, and patent foramen ovale.
- New guidance on temporary interruption of antithrombotic therapy, cancer-associated stroke, and virtual care delivery.
Conclusions:
- The 2020 CSBPR provide comprehensive, updated guidance for clinicians to prevent ischemic stroke recurrence.
- The recommendations emphasize managing modifiable risk factors and adapting to new care delivery models like virtual health.
Abstract:
The 2020 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for the Secondary Prevention of Stroke includes current evidence-based recommendations and expert opinions intended for use by clinicians across a broad range of settings. They provide guidance for the prevention of ischemic stroke recurrence through the identification and management of modifiable vascular risk factors. Recommendations address triage, diagnostic testing, lifestyle behaviors, vaping, hypertension, hyperlipidemia, diabetes, atrial fibrillation, other cardiac conditions, antiplatelet and anticoagulant therapies, and carotid and vertebral artery disease. This update of the previous 2017 guideline contains several new or revised recommendations. Recommendations regarding triage and initial assessment of acute transient ischemic attack (TIA) and minor stroke have been simplified, and selected aspects of the etiological stroke workup are revised. Updated treatment recommendations based on new evidence have been made for dual antiplatelet therapy for TIA and minor stroke; anticoagulant therapy for atrial fibrillation; embolic strokes of undetermined source; low-density lipoprotein lowering; hypertriglyceridemia; diabetes treatment; and patent foramen ovale management. A new section has been added to provide practical guidance regarding temporary interruption of antithrombotic therapy for surgical procedures. Cancer-associated ischemic stroke is addressed. A section on virtual care delivery of secondary stroke prevention services in included to highlight a shifting paradigm of care delivery made more urgent by the global pandemic. In addition, where appropriate, sex differences as they pertain to treatments have been addressed. The CSBPR include supporting materials such as implementation resources to facilitate the adoption of evidence into practice and performance measures to enable monitoring of uptake and effectiveness of recommendations.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care

